News

Biopsy data showed that injection of the drug into the muscles of a series of Duchenne muscular dystrophy (DMD) patients successfully induced dystrophin production in each patient. The

Drugs for Neglected Diseases initiative (DNDi) will collaborate with BDSI on a non-exclusive basis in the design and conduct of a research and clinical development program to assess

The lots are being voluntarily recalled as a precaution following a notification issued by China’s State Food and Drug Administration (SFDA) of the possibility of a flaw in

“In the quarter, and in the past year, we’ve taken decisive action as a BioPharma leader to become leaner and more agile,” said James M. Cornelius, chairman and

Rexin-G was well tolerated and there was no dose-limiting toxicity. At dose level I, three patients achieved stable disease with no tumor progression; and at dose level II,

According to Life Technologies, this device simplifies protein analysis workflows by automating Western blotting; a laboratory technique used in a variety of life science research applications, including studies

Sales growth was driven primarily by higher volume and new products, including oxycodone hydrochloride extended-release tablets, which accounted for about $100 million in first-quarter sales. Unfavorable foreign exchange

Perrey joined the company from Third Wave/Hologic Japan and previously held various positions in the Japanese in-vitro diagnostic industry (especially in infectious diseases segments). He was also involved

Adjusted net income, excluding stock option expense and certain other expenses, increased 3% to $1,124 million in the fourth quarter of 2008 compared to $1,088 million in the